BMY

Bristol-Myers Squibb makes drugs for cancer, cardiovascular disease, and immunology. Their cancer drug Opdivo competes with Merck's Keytruda. The company has been acquiring other pharmaceutical companies to refresh its drug pipeline as some older products lose patent protection.